Related Experiment Video
Updated: Jul 18, 2026

04:01
Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery
Published on: August 9, 2024
Automatic detection of emboli in the TCD RF signal using principal component analysis
1Department of Medical Physics, University Hospitals of Leicester NHS Trust, Leicester, UK.
Ultrasound in Medicine & Biology
|December 16, 2006
Summary
Principal component analysis (PCA) was used to analyze transcranial Doppler (TCD) radio-frequency signals for detecting embolic signals. While not yet clinically accurate, this method shows promise for automated embolic detection.
Area of Science:
- Medical imaging
- Signal processing
- Neurosonology
Background:
- Transcranial Doppler (TCD) monitoring provides valuable data during ultrasonic assessments.
- Radio-frequency (RF) signals contain information beyond standard TCD monitoring.
- Embolic signals exhibit distinct, predictable patterns within the RF signal, suitable for automated detection.
Purpose of the Study:
- To characterize variations in embolic signal shape using principal component analysis (PCA).
- To develop and test PCA-based algorithms for discriminating between embolic and artifact signals in TCD RF data.
- To assess the potential of PCA for automated embolic signal detection in clinical settings.
Main Methods:
- Utilized principal component analysis (PCA) on training datasets of in vitro and in vivo TCD RF signals.
- Applied PCA to identify characteristic variations in embolic signal shapes.
- Developed algorithms using PCA to differentiate between embolic signals and artifacts in unseen data.
Main Results:
- PCA effectively characterized typical variations in embolic signal shapes within TCD RF signals.
- The developed algorithms demonstrated the ability to discriminate between embolic and artifact signals.
- Current accuracy levels are insufficient for direct clinical application.
Conclusions:
- PCA is a viable technique for analyzing TCD RF signals to detect embolic events.
- The study highlights the potential of PCA for developing automated embolic detection systems.
- Further development is needed to achieve the accuracy required for clinical deployment.

